Join us on Wednesday, March 19 at 10 a.m. CST for the next installment of ASGCT's Molecular Therapy Presents webinar series: Immunotherapy in Autoimmune Disease. This event is FREE for ASGCT members.
With seven CAR T cell therapies currently approved in the United States to treat certain forms of cancer, researchers and clinicians are exploring other applications to treat autoimmune diseases. Following the ground-breaking first report of a patient with severe systemic lupus erythematosus who was successfully treated with CD19 CAR T cells, clinical trials of CAR T cell therapies for lupus nephritis, scleroderma, myositis, and multiple sclerosis have taken flight across the world.
Moderator
Boris Fehse, PhDUniversity Medical Centre Hamburg-Eppendorf